- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00741247
Mediastinal Staging of Lung Cancer With EBUS-TBNA and EUS-B-FNA
June 23, 2009 updated by: National Cancer Center, Korea
Minimally Invasive Mediastinal Staging of Potentially Operable Lung Cancer With Endobronchial Ultrasound Guided Transbronchial Needle Aspiration(EBUS-TBNA) and Transesophageal Aspiration Using Ultrasonic Bronchoscope (EUS-B-FNA)
The purpose of this study is to find a role of EUS-B-FNA in the mediastinal staging of potentially operable lung cancer.
The investigators perform EBUS-TBNA and EUS-B-FNA on potentially operable lung cancer patients.
The investigators perform EBUS(+/- TBNA) and EUS-B (ultrasonographic examination through the esophagus) on all subjects.
EUS-B-FNA will be performed on inaccessible nodes or difficult nodes to be sampled by EBUS-TBNA.
Additional diagnostic values of EUS-B-FNA as compared to EBUS-TBNA alone will be estimated.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Gyeonggi-do, Korea, Republic of
- NCCKorea
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Histologically confirmed or strongly suspected potentially operable non-small cell lung cancer (NSCLC)
- Potentially operable patients
Exclusion Criteria:
After staging work-up for NSCLC, including bronchoscopy,CT of the chest and upper abdomen, integrated PET/CT and brain MRI (and/or bone scan)
- M1 disease
- Inoperable T4 disease
- Mediastinal infiltration or extranodal invasion of the mediastinal lymph node visible on chest CT.
- Confirmed supraclavicular lymph node metastasis
- Pancoast tumors
- Medically inoperable patients
- Contraindications for bronchoscopy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The diagnostic values of EBUS-TBNA plus EUS-B-FNA as compared to EBUS-TBNA alone
Time Frame: June 2009
|
June 2009
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The Proportion and the location of lymph nodes accessible by EBUS-TBNA and EUS-B-FNA.
Time Frame: June 2009
|
June 2009
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2008
Primary Completion (Actual)
March 1, 2009
Study Completion (Actual)
March 1, 2009
Study Registration Dates
First Submitted
August 25, 2008
First Submitted That Met QC Criteria
August 25, 2008
First Posted (Estimate)
August 26, 2008
Study Record Updates
Last Update Posted (Estimate)
June 24, 2009
Last Update Submitted That Met QC Criteria
June 23, 2009
Last Verified
June 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NCCCTS-08-332
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.